Literature DB >> 17620293

Gene expression profiling and gene copy-number changes in malignant mesothelioma cell lines.

Claudia Zanazzi1, Remko Hersmus, Imke M Veltman, Ad J M Gillis, Ellen van Drunen, H Berna Beverloo, Joost P J J Hegmans, Marielle Verweij, Bart N Lambrecht, J Wolter Oosterhuis, Leendert H J Looijenga.   

Abstract

Malignant mesothelioma (MM) is an asbestos-induced tumor that acquires aneuploid DNA content during the tumorigenic process. We used instable MM cell lines as an in vitro model to study the impact of DNA copy-number changes on gene expression profiling, in the course of their chromosomal redistribution process. Two MM cell lines, PMR-MM2 (early passages of in vitro culture) and PMR-MM7 (both early and late passages of in vitro culture), were cytogenetically characterized. Genomic gains and losses were precisely defined using microarray-based comparative genomic hybridization (array-CGH), and minimal overlapping analysis led to the identification of the common unbalanced genomic regions. Using the U133Plus 2.0 Affymetrix gene chip array, we analyzed PMR-MM7 early and late passages for genome-wide gene expression, and correlated the differentially expressed genes with copy-number changes. The presence of a high number of genetic imbalances occurring from early to late culture steps reflected the tendency of MM cells toward genomic instability. The selection of specific chromosomal abnormalities observed during subsequent cultures demonstrated the spontaneous evolution of the cancer cells in an in vitro environment. MM cell lines were characterized by copy-number changes associated with the TP53 apoptotic pathway already present at the first steps of in vitro culture. Prolonged culture led to acquisition of additional chromosomal copy-number changes associated with dysregulation of genes involved in cell adhesion, regulation of mitotic cell cycle, signal transduction, carbohydrate metabolism, motor activity, glycosaminoglycan biosynthesis, protein binding activity, lipid transport, ATP synthesis, and methyltransferase activity. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17620293     DOI: 10.1002/gcc.20475

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  8 in total

1.  Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines.

Authors:  Geula Klorin; Ester Rozenblum; Oleg Glebov; Robert L Walker; Yoonsoo Park; Paul S Meltzer; Ilan R Kirsch; Frederic J Kaye; Anna V Roschke
Journal:  Cancer Genet       Date:  2013-07-05

2.  Genome-wide profile of pleural mesothelioma versus parietal and visceral pleura: the emerging gene portrait of the mesothelioma phenotype.

Authors:  Oluf Dimitri Røe; Endre Anderssen; Eli Helge; Caroline Hild Pettersen; Karina Standahl Olsen; Helmut Sandeck; Rune Haaverstad; Steinar Lundgren; Erik Larsson
Journal:  PLoS One       Date:  2009-08-07       Impact factor: 3.240

3.  Genomic instability of osteosarcoma cell lines in culture: impact on the prediction of metastasis relevant genes.

Authors:  Roman Muff; Prisni Rath; Ram Mohan Ram Kumar; Knut Husmann; Walter Born; Michael Baudis; Bruno Fuchs
Journal:  PLoS One       Date:  2015-05-19       Impact factor: 3.240

4.  MicroRNA and mRNA features of malignant pleural mesothelioma and benign asbestos-related pleural effusion.

Authors:  Guntulu Ak; Sandra C Tomaszek; Farhad Kosari; Muzaffer Metintas; James R Jett; Selma Metintas; Huseyin Yildirim; Emine Dundar; Jie Dong; Marie Christine Aubry; Dennis A Wigle; Charles F Thomas
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  CDKN2A copy number and p16 expression in malignant pleural mesothelioma in relation to asbestos exposure.

Authors:  Eeva Kettunen; Sauli Savukoski; Kaisa Salmenkivi; Tom Böhling; Esa Vanhala; Eeva Kuosma; Sisko Anttila; Henrik Wolff
Journal:  BMC Cancer       Date:  2019-05-28       Impact factor: 4.430

6.  Phenotypes and karyotypes of human malignant mesothelioma cell lines.

Authors:  Vandana Relan; Leanne Morrison; Kylie Parsonson; Belinda E Clarke; Edwina E Duhig; Morgan N Windsor; Kevin S Matar; Rishendran Naidoo; Linda Passmore; Elizabeth McCaul; Deborah Courtney; Ian A Yang; Kwun M Fong; Rayleen V Bowman
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

7.  Effects of aneuploidy on genome structure, expression, and interphase organization in Arabidopsis thaliana.

Authors:  Bruno Huettel; David P Kreil; Marjori Matzke; Antonius J M Matzke
Journal:  PLoS Genet       Date:  2008-10-17       Impact factor: 5.917

Review 8.  Use of preclinical models for malignant pleural mesothelioma.

Authors:  Marie Shamseddin; Joanna Obacz; Mathew J Garnett; Robert Campbell Rintoul; Hayley Elizabeth Francies; Stefan John Marciniak
Journal:  Thorax       Date:  2021-03-10       Impact factor: 9.139

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.